Whimpers and bangs: Of death and dying in the nervous system

Journal of Child Neurology

Volumn 13, Issue 7, 1998, Pages 307-312

  Schor, Nina Felice ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYTOCHROME C; DNA; DOPAMINE; HUNTINGTIN; LEVODOPA; MERCURY; NERVE GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; CHILDHOOD DISEASE; CYTOTOXICITY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; MERCURIALISM; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SEIZURE; SPINAL MUSCULAR ATROPHY; VIRUS ENCEPHALITIS;

EID: 0031867734     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300701     Document Type: Review

References (50)

1. Tomei LD, Cope FO, eds: Apoptosis: The molecular basis of cell death. Curr Commun Cell Molec Biol, vol 3. Cold Spring Harbor, Cold Spring Harbor Lab Press, 1991.
2. Stewart BW: Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 1994;86: 1286-1296.
3. Hartsell TL, Yalowich JC, Ritke MK, et al: Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin. J Pharmacol Exp Ther 1995;275: 479-485.
4. Raff MC: Social controls on cell survival and cell death. Nature 1992;356:397-400.
5. Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132.
6. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136.
7. Bredesen DE: Neural apoptosis. Ann Neurol 1996;38:839-851.
8. Kane DJ, Ord T, Anton R, Bredesen DE: Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 1995;40:269-275.
9. Kane DJ, Sarafian TA, Anton R, et al: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993;262:1274-1277.
10. Albrecht H, Tschopp J, Jongeneel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF. FEBS Lett 1994;351:45-48.
11. Forrest VJ, Kang YH, McClain DE, et al: Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med 1994;16: 675-684.
12. Ratan RR, Murphy TH, Baraban JM: Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 1994;14:4385-4392.
13. Sandstrom PA, Mannie MD, Buttke TM: Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J Leukocyte Biol 1994;55: 221-226.
14. Fabisiak JP, Kagan VE, Ritov VB, et al: Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis. Am J Physiol: Cell Physiol 1997;41:C675-C684.
15. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
16. El-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
17. Strasser A, Harris AW, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994;79:329-339.
18. Barbacid M: Nerve growth factor: A tale of two receptors. Oncogene 1993;8:2033-2042.
19. Hempstead B, Martin-Zanca D, Kaplan DR, et al: High-affinity NGF binding requires co-expression of the trk protooncogene and the low affinity NGF receptor. Nature 1991;350:678-683.
20. Rabizadeh S, Oh J, Zhong L-T, et al: Induction of apoptosis by the low-affinity NGF receptor. Science 1993;261:345-348.
21. Cortazzo MH, Kassis ES, Sproul KA, Schor NF: Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor. J Neurosci 1996;16:3895-3899.
22. Gelbard HA, Boustany R-M, Schor NF: Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. Pediatr Neurol 1997;16:93-97.
23. Loo DT, Copani A, Pike CJ, et al: Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 1993;90:7951-7955.
24. Ziv I, Melamed E, Nardi N, et al: Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett 1994;170:136-140.
25. Walkinshaw G, Waters CM: Induction of apoptosis in cate-cholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. J Clin Invest 1995;95:2458-2464.
26. Burke JR, Enghild JJ, Martin ME, et al: Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996;2:347-350.
27. Lefebre S, Burglen L, Reboullet S, et al: Identification and characterization of a spinal muscular atrophy determining gene. Cell 1995;80:155-165.
28. Roy N, Mahadevan MS, McLean M, et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-178.
29. Lane SC, Jolly RD, Schmechel DE, et al: Apoptosis as the mechanism of neurodegeneration in Batten's disease. J Neurochem 1996;67:677-683.
30. Lerner TJ, Boustany R-M, Anderson JW, et al and the International Batten Disease Consortium: Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995;82:949-957.
31. Kunimoto M: Methyl mercury induces apoptosis of rat cerebellar neurons in primary culture. Biochem Biophys Res Commun 1994;2049:310-317.
32. Gelbard HA, James H, Sharer L, et al: Apoptotic neurons in brains of pediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995;21:208-217.
33. Weller RO, Swash M, McLellan DL, Scholtz CL: Clinical Neuropathology. New York, Springer-Verlag, 1983, pp 146-147.
34. Ahmadieh H, Sajjadi SH, Azarmina M, Kalani H: Association of herpetic encephalitis with acute retinal necrosis syndrome. Ann Ophthalmol 1991;23:215-219.
35. Degirolami U, Crowell RM, Marcoux FW: Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropathol Exp Neurol 1984;43:57-71.
36. Garcia JH, Chen H, Li Y, et al: Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 1993;142:623-635.
37. Goto K, Ishige A, Sekiguchi K, et al: Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res 1990;534:299-302.
38. Kihara S, Shiraishi T, Nakagawa S, et al: Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci Lett 1994;175:133-136.
39. Gwag BJ, Lobner D, Koh J, et al: Blockade of glutamate receptors during oxygen or glucose deprivation unmasks apoptosis in cultured cortical neurons. Soc Neurosci Abst 1994;24:248.
40. Wasterlain C, Thompson KW: Status epilepticus causes delayed neuronal death with DNA fragmentation in the immature hippocampus, abstract. Neurol 1997;48:A391.
41. Linnik MD, Zobrist RH, Hatfield MD: Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993;24:2002-2009.
42. Crumrine RC, Thomas AL, Morgan PF: Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood flow Metab 1994;14:887-891.
43. Oren M: The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 1992;11: 141-148.
44. Savill J: Apoptosis in disease. Eur J Clin Invest 1994;24:715-723.
45. Sachs L, Lotem J: Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 1993;82:15-21.
46. Dole M, Nunez G, Merchant AK, et al: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994;54: 3253-3259.
47. Tyurina YY, Tyurin VA, Carta G, et al: Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells. Arch Biochem Biophys 1997;344:413-423.
48. Cortazzo M, Schor NF: Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2. Cancer Res 1996;56:1109-1203.
49. Cortazzo MH, Kassis ES, Sproul KA, Schor NF: Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor. J Neurosci 1996;16:3895-3899.
50. LeSauteur L, Wei L, Gibbs BF, Saragovi HU: Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 1995;270:6564-6569.